These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 34082425

  • 1. MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
    Klimek L, Berger WE, Bousquet J, Keith PK, Smith P, Sole D, Scadding G, Kuhl HC, Nguyen DT, Kopietz F, Koltun A.
    Int Arch Allergy Immunol; 2021; 182(11):1026-1035. PubMed ID: 34082425
    [Abstract] [Full Text] [Related]

  • 2. Intranasal spray medications for maintenance therapy of allergic rhinitis.
    Berger WE, Meltzer EO.
    Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312
    [Abstract] [Full Text] [Related]

  • 3. Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.
    Scadding G, Price D, El-Shanawany T, Ahmed S, Ray J, Sargur R, Kumar N.
    BMJ Open; 2017 Apr 24; 7(4):e014777. PubMed ID: 28442578
    [No Abstract] [Full Text] [Related]

  • 4. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children.
    Berger W, Bousquet J, Fox AT, Just J, Muraro A, Nieto A, Valovirta E, Wickman M, Wahn U.
    Allergy; 2016 Aug 24; 71(8):1219-22. PubMed ID: 27043452
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia.
    Ilyina NI, Edin AS, Astafieva NG, Lopatin AS, Sidorenko IV, Ukhanova OP, Khanova FM.
    Int Arch Allergy Immunol; 2019 Aug 24; 178(3):255-263. PubMed ID: 30677766
    [Abstract] [Full Text] [Related]

  • 6. MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Denmark.
    Haahr PA, Jacobsen C, Christensen ME.
    Int Forum Allergy Rhinol; 2019 Apr 24; 9(4):388-395. PubMed ID: 30659752
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis.
    Zhong Z, Xun Y, Shi X, Guan B, Wang M.
    Eur Arch Otorhinolaryngol; 2022 May 24; 279(5):2457-2464. PubMed ID: 34415405
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L, Demoly P, Price D.
    Expert Rev Clin Pharmacol; 2016 May 24; 9(5):705-14. PubMed ID: 26839083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Real-life effectiveness of MP-AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy.
    Kaulsay R, Nguyen DT, Kuhl HC.
    Immun Inflamm Dis; 2018 Dec 24; 6(4):456-464. PubMed ID: 30306729
    [Abstract] [Full Text] [Related]

  • 14. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L, Price D, Gálffy G, Emmeluth M, Koltun A, Kopietz F, Nguyen DT, van Weissenbruch R, Pohl W, Kuhl HC, Scadding G, Mullol J.
    Int Arch Allergy Immunol; 2020 Dec 24; 181(10):754-764. PubMed ID: 32829329
    [Abstract] [Full Text] [Related]

  • 15. The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review.
    Tantilipikorn P, Kirtsreesakul V, Bunnag C, Vangveeravong M, Thanaviratananich S, Chusakul S.
    J Asthma Allergy; 2024 Dec 24; 17():667-679. PubMed ID: 39045291
    [Abstract] [Full Text] [Related]

  • 16. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B, Sedaghat AR, Caldwell-Tarr A, Dufour R.
    J Manag Care Spec Pharm; 2016 Dec 24; 22(12):1426-1436. PubMed ID: 27882840
    [Abstract] [Full Text] [Related]

  • 17. A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis.
    Zhou B, Cheng L, Pan J, Wang H, Jin Y, Zhao C, Lin P, Tan G, Fang H, Zhang H, Zhou H, Dong Y, Kuhl HC, Ramalingam RK, Nguyen DT.
    Pulm Ther; 2023 Sep 24; 9(3):411-427. PubMed ID: 37580498
    [Abstract] [Full Text] [Related]

  • 18. A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US.
    Prenner BM.
    J Asthma Allergy; 2016 Sep 24; 9():135-43. PubMed ID: 27468241
    [Abstract] [Full Text] [Related]

  • 19. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
    Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W.
    Allergy Asthma Proc; 2012 Sep 24; 33(4):324-32. PubMed ID: 22856633
    [Abstract] [Full Text] [Related]

  • 20. New patents of fixed combinations of nasal antihistamines and corticosteroids in allergic rhinitis.
    Wolthers OD.
    Recent Pat Inflamm Allergy Drug Discov; 2013 Sep 24; 7(3):223-8. PubMed ID: 23862774
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.